Cullinan Therapeutics CGEM
NASDAQ CGEM
$11.35 +0.12 (+1.07%)
At close: Nov 11, 2026 · 4:00 PM EST

Cullinan Therapeutics (CGEM) FCF Margin (2021)

Updated

Cullinan Therapeutics (CGEM) recorded FCF Margin of -229.28% in FY2021.

Analysis

Cullinan Therapeutics (CGEM) FCF Margin (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 33.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.03%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 41.97%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.51%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 52.85%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.25%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 57.81%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 28.96%
10 Cullinan Therapeutics 722.60 Mn -1.13 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -8.00%
API Access

Cullinan Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=CGEM&period=max&api_key=YOUR_API_KEY